143 related articles for article (PubMed ID: 7933689)
21. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
22. [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].
Ohmori H; Ohashi T; Aso Y; Kumamoto Y; Hisazumi H; Shiraiwa Y; Kurita T; Shimazaki J; Ohkawa T; Ogawa H
Hinyokika Kiyo; 1988 Dec; 34(12):2101-10. PubMed ID: 3071123
[TBL] [Abstract][Full Text] [Related]
23. The Role of TPS and TPA in the Diagnostics of Distant Metastases.
Kucera R; Topolcan O; Fiala O; Kinkorova J; Treska V; Zedníková I; Slouka D; Simanek V; Safanda M; Babuska V
Anticancer Res; 2016 Feb; 36(2):773-7. PubMed ID: 26851038
[TBL] [Abstract][Full Text] [Related]
24. [Fundamental and clinical evaluation of a tissue polypeptide antigen (TPA) kit--TPA as a tumor marker].
Masaka M; Yoshimi T
Radioisotopes; 1983 Dec; 32(12):633-6. PubMed ID: 6676781
[No Abstract] [Full Text] [Related]
25. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A
Anticancer Res; 1996; 16(6B):3793-8. PubMed ID: 9042259
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of measuring serum CA 15-3, TPA, and TPS in women with breast cancer.
Sliwowska I; Kopczyński Z; Grodecka-Gazdecka S
Postepy Hig Med Dosw (Online); 2006; 60():295-9. PubMed ID: 16767053
[TBL] [Abstract][Full Text] [Related]
27. [Basic and clinical evaluation of a novel immunoradiometric assay kit for free thyroxine].
Misaki T; Kousaka T; Miyamoto S; Takeuchi R; Kasagi K; Konishi J
Kaku Igaku; 1994 Jun; 31(6):629-35. PubMed ID: 8072238
[TBL] [Abstract][Full Text] [Related]
28. [The evaluation of the newly produced assay kit for the cytokeratin fragment, "ball ELSA CYFRA21-1"].
Kimura Y; Ata M; Nakamura S; Fujii T; Kawamura T; Tanada S; Hamamoto K
Kaku Igaku; 1994 Feb; 31(2):199-206. PubMed ID: 7509886
[TBL] [Abstract][Full Text] [Related]
29. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
30. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
[TBL] [Abstract][Full Text] [Related]
31. [Fundamental and clinical evaluation of a TPA immunoradiometric assay kit].
Kimura Y; Takechi T; Ata M; Miyakawa N; Fujii T; Iio A; Hamamoto K
Kaku Igaku; 1988 Jul; 25(7):665-72. PubMed ID: 3184540
[No Abstract] [Full Text] [Related]
32. Tissue polypeptide-specific antigen in renal cell carcinoma.
Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
[TBL] [Abstract][Full Text] [Related]
33. [Fundamental evaluation of ELSA.F-beta HCG kit as an immunoradiometric assay specific for serum beta HCG].
Omori S; Suehiro M; Fukuchi M
Kaku Igaku; 1992 Jun; 29(6):709-16. PubMed ID: 1379310
[TBL] [Abstract][Full Text] [Related]
34. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
[TBL] [Abstract][Full Text] [Related]
35. The tumor markers TPA, TPS, TPACYK and CYFRA 21-1 react differently with the keratins 8, 18 and 19.
Bodenmüller H; Donié F; Kaufmann M; Banauch D
Int J Biol Markers; 1994; 9(2):70-4. PubMed ID: 7523544
[TBL] [Abstract][Full Text] [Related]
36. On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18, and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum.
Mellerick DM; Osborn M; Weber K
Oncogene; 1990 Jul; 5(7):1007-17. PubMed ID: 1695723
[TBL] [Abstract][Full Text] [Related]
37. A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients.
Silén A; Wiklund B; Andersson EL; Nilsson S
Scand J Clin Lab Invest; 1995 Apr; 55(2):153-61. PubMed ID: 7545308
[TBL] [Abstract][Full Text] [Related]
38. [The diagnostic value of determination of tissue polypeptide specific antigen (TPS) in serum of women with breast cancer].
Kopczyński Z; Woźniak A
Ginekol Pol; 1997 Feb; 68(2):78-82. PubMed ID: 9499001
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tissue-polypeptide specific antigen (TPS) in bladder cancer.
Menendez V; Galan JA; Fernandez-Suarez A; Lopez S; Alcover J; Calpena R; Filella X
Anticancer Res; 2002; 22(6B):3713-6. PubMed ID: 12552981
[TBL] [Abstract][Full Text] [Related]
40. [Fundamental and clinical evaluation of an immunoradiometric assay procedure "Amerwell AFP" for estimation of serum alpha-fetoprotein].
Suzuki M
Radioisotopes; 1988 Apr; 37(4):225-8. PubMed ID: 2456592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
